Achieve Life Sciences (ACHV) Return on Sales (2010 - 2016)

Achieve Life Sciences' (ACHV) quarterly Return on Sales came in at 0.0% in Q1 2016, up 69.46% on a QoQ basis from 0.0% in Q4 2015.

Achieve Life Sciences (ACHV) Return on Sales (2010 - 2016) Analysis & Trends

Achieve Life Sciences (ACHV) has 6 years of Return on Sales data on file, last reported at 0.0% in Q1 2016.

Quarterly Return on Sales changed N/A year-over-year to 0.0% in Q1 2016, while the trailing twelve-month figure through Mar 2016 was 0.0% (changed N/A YoY) and the FY2015 annual result came in at 0.0%, changed N/A from the prior year.
Return on Sales rose to 0.0% in Q1 2016, from 0.0% in the prior quarter.
In the past five years, Return on Sales ranged from a high of 0.02% in Q2 2012 to a low of 0.05% in Q1 2012.
A 4-year average of 0.01% and a median of 0.01% in 2013 frame the typical range for Return on Sales.
The widest YoY moves for Return on Sales: up 12 bps in 2012, down 3 bps in 2012.
Tracing ACHV's Return on Sales over 4 years: stood at 0.04% in 2012, then jumped by 69 bps to 0.01% in 2013, then surged by 83 bps to 0.0% in 2015, then jumped by 69 bps to 0.0% in 2016.
The last three Return on Sales figures came in at 0.0% (Q1 2016), 0.0% (Q4 2015), and 0.01% (Q3 2013), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	0.00%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	0.00%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	0.00%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	0.00%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	0.00%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.00%
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	0.00%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	0.00%
10	Achieve Life Sciences	330.88 Mn	330.88 Mn	-	-

Download Data